It is therefore practically significant to make changes and to enrich the treatment mode of lung cancer.
← all excerpts
Investigating efficacy of "microbiota modulation of the gut-lung Axis" combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial.
1
—
—